• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

八聚精氨酸修饰的聚乳酸-乙醇酸共聚物纳米颗粒经鼻内和静脉给药可促进洛哌丁胺向中枢神经系统的递送。

Intranasal and intravenous administration of octa-arginine modified poly(lactic-co-glycolic acid) nanoparticles facilitates central nervous system delivery of loperamide.

作者信息

O'Donnell Aisling, Moollan Azeema, Baneham Samantha, Ozgul Melike, Pabari Ritesh M, Cox Dermot, Kirby Brian P, Ramtoola Zebunnissa

机构信息

School of Pharmacy, Royal College of Surgeons in Ireland, Dublin 2, Ireland.

出版信息

J Pharm Pharmacol. 2015 Apr;67(4):525-36. doi: 10.1111/jphp.12347. Epub 2014 Dec 17.

DOI:10.1111/jphp.12347
PMID:25515568
Abstract

OBJECTIVES

The potential of poly(lactic-co-glycolic acid) (PLGA) nanoparticles (NPs) surface modified with octa-arginine (R8) for central nervous system (CNS) delivery was investigated.

METHODS

PLGA NPs containing coumarin-6 or loperamide were surface modified using R8 and characterised for size, zeta potential, drug loading and release. We examined the cellular uptake of NPs in Madin-Darby Canine Kidney (MDCK) cells and CNS delivery of loperamide in a mouse model following intranasal (i.n.) and intravenous (i.v.) administration.

KEY FINDINGS

NPs were 300-350 nm in diameter and of negative zeta potential which neutralised on R8 conjugation. Cellular uptake of R8-PLGA NPs was rapid compared with PLGA NPs and correlated with a high antinociceptive effect in mice by both the i.n. and i.v. routes. Little antinociceptive effect for PLGA NPs was observed reflecting their slow uptake in the in-vitro cell model.

CONCLUSION

This study demonstrates the potential of R8-PLGA NPs as carriers of therapeutic agents to the CNS.

摘要

目的

研究用八聚精氨酸(R8)表面修饰的聚乳酸-乙醇酸共聚物(PLGA)纳米颗粒(NPs)用于中枢神经系统(CNS)给药的潜力。

方法

用R8对含有香豆素-6或洛哌丁胺的PLGA NPs进行表面修饰,并对其尺寸、zeta电位、载药量和释放情况进行表征。我们检测了NPs在犬肾上皮细胞(MDCK)中的细胞摄取情况,以及在小鼠模型中经鼻内(i.n.)和静脉内(i.v.)给药后洛哌丁胺的CNS递送情况。

主要发现

NPs直径为300 - 350nm,zeta电位为负,在与R8偶联后被中和。与PLGA NPs相比,R8-PLGA NPs的细胞摄取迅速,并且通过i.n.和i.v.途径在小鼠中均表现出高抗伤害感受作用。观察到PLGA NPs的抗伤害感受作用很小,这反映了它们在体外细胞模型中的摄取缓慢。

结论

本研究证明了R8-PLGA NPs作为治疗药物向CNS递送载体的潜力。

相似文献

1
Intranasal and intravenous administration of octa-arginine modified poly(lactic-co-glycolic acid) nanoparticles facilitates central nervous system delivery of loperamide.八聚精氨酸修饰的聚乳酸-乙醇酸共聚物纳米颗粒经鼻内和静脉给药可促进洛哌丁胺向中枢神经系统的递送。
J Pharm Pharmacol. 2015 Apr;67(4):525-36. doi: 10.1111/jphp.12347. Epub 2014 Dec 17.
2
Comparative evaluation of the degree of pegylation of poly(lactic-co-glycolic acid) nanoparticles in enhancing central nervous system delivery of loperamide.聚(乳酸-共-乙醇酸)纳米粒的聚乙二醇化程度对增强洛哌丁胺中枢神经系统递送的比较评价。
J Pharm Pharmacol. 2013 Oct;65(10):1473-81. doi: 10.1111/jphp.12125. Epub 2013 Aug 1.
3
Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel.用于多西他赛口服递送的聚丙交酯-维生素E衍生物/蒙脱石纳米颗粒制剂
Biomaterials. 2009 Jul;30(19):3297-306. doi: 10.1016/j.biomaterials.2009.02.045. Epub 2009 Mar 19.
4
Mechanisms of chitosan-coated poly(lactic-co-glycolic acid) nanoparticles for improving oral absorption of 7-ethyl-10-hydroxycamptothecin.壳聚糖包覆的聚(乳酸-共-乙醇酸)纳米粒提高 7-乙基-10-羟基喜树碱口服吸收的机制。
Nanotechnology. 2013 Jun 21;24(24):245101. doi: 10.1088/0957-4484/24/24/245101. Epub 2013 May 23.
5
Effects of surface modification of PLGA-PEG-PLGA nanoparticles on loperamide delivery efficiency across the blood-brain barrier.PLGA-PEG-PLGA 纳米粒表面修饰对洛哌丁胺透过血脑屏障递送效率的影响。
J Biomater Appl. 2013 Mar;27(7):909-22. doi: 10.1177/0885328211429495. Epub 2011 Dec 29.
6
Transient aggregation of chitosan-modified poly(d,l-lactic-co-glycolic) acid nanoparticles in the blood stream and improved lung targeting efficiency.壳聚糖修饰的聚(d,l-乳酸-共-乙醇酸)纳米粒在血流中的短暂聚集及提高的肺靶向效率。
J Colloid Interface Sci. 2016 Oct 15;480:102-108. doi: 10.1016/j.jcis.2016.07.006. Epub 2016 Jul 6.
7
Tetracycline-grafted PLGA nanoparticles as bone-targeting drug delivery system.四环素接枝的聚乳酸-羟基乙酸共聚物纳米颗粒作为骨靶向给药系统
Int J Nanomedicine. 2015 Sep 8;10:5671-85. doi: 10.2147/IJN.S88798. eCollection 2015.
8
Preparation and in vitro evaluation of thienorphine-loaded PLGA nanoparticles.载硫喷妥钠 PLGA 纳米粒的制备及体外评价。
Drug Deliv. 2016;23(3):787-93. doi: 10.3109/10717544.2014.916765. Epub 2014 May 28.
9
Development of poly(lactic-co-glycolic) acid nanoparticles-embedded hyaluronic acid-ceramide-based nanostructure for tumor-targeted drug delivery.用于肿瘤靶向给药的聚(乳酸-乙醇酸)酸纳米颗粒包埋的基于透明质酸-神经酰胺的纳米结构的研发。
Int J Pharm. 2014 Oct 1;473(1-2):426-33. doi: 10.1016/j.ijpharm.2014.07.038. Epub 2014 Jul 28.
10
Preparation and in vitro evaluation of meloxicam-loaded PLGA nanoparticles on HT-29 human colon adenocarcinoma cells.载美洛昔康 PLGA 纳米粒的制备及其对 HT-29 人结肠腺癌细胞的体外评价。
Drug Dev Ind Pharm. 2012 Sep;38(9):1107-16. doi: 10.3109/03639045.2011.641562. Epub 2012 Feb 20.

引用本文的文献

1
The Prediction of the In Vitro Release Curves for PLGA-Based Drug Delivery Systems with Neural Networks.基于神经网络的聚乳酸-羟基乙酸共聚物药物递送系统体外释放曲线预测
Pharmaceutics. 2025 Apr 14;17(4):513. doi: 10.3390/pharmaceutics17040513.
2
Nanomaterials as drug delivery agents for overcoming the blood-brain barrier: A comprehensive review.纳米材料作为克服血脑屏障的药物递送剂:综述
ADMET DMPK. 2023 Oct 31;12(1):63-105. doi: 10.5599/admet.2043. eCollection 2024.
3
Nanocarriers Call the Last Shot in the Treatment of Brain Cancers.
纳米载体在脑癌治疗中吹响终场哨。
Technol Cancer Res Treat. 2022 Jan-Dec;21:15330338221080974. doi: 10.1177/15330338221080974.
4
A comparison of models for the analysis of the kinetics of drug release from PLGA-based nanoparticles.基于聚乳酸-羟基乙酸共聚物(PLGA)的纳米颗粒药物释放动力学分析模型的比较
Heliyon. 2020 Feb 28;6(2):e03451. doi: 10.1016/j.heliyon.2020.e03451. eCollection 2020 Feb.
5
Effect of Size and Concentration of PLGA-PEG Nanoparticles on Activation and Aggregation of Washed Human Platelets.聚乳酸-羟基乙酸共聚物-聚乙二醇纳米颗粒的尺寸和浓度对洗涤后人体血小板活化和聚集的影响
Pharmaceutics. 2019 Oct 4;11(10):514. doi: 10.3390/pharmaceutics11100514.
6
Nanomaterial-based blood-brain-barrier (BBB) crossing strategies.基于纳米材料的血脑屏障(BBB)穿越策略。
Biomaterials. 2019 Dec;224:119491. doi: 10.1016/j.biomaterials.2019.119491. Epub 2019 Sep 14.